News

Morningstar3mon
Second Data Safety Monitoring Board Issues Positive Recommendation to Continue BriaCell’s Phase 3 Study in Metastatic Breast Cancer - Morningstar
The Data Safety Monitoring Board (DSMB) identified no safety concerns, and recommended continuation of BriaCell’s pivotal Phase 3 study of Bria-IMT™ plus immune check point inhibitor in ...
Nasdaq4mon
Belite Bio's Phase 3 DRAGON Trial for Tinlarebant Recommended to Continue Without Modifications by Data Safety Monitoring Board - Nasdaq
The independent Data Safety Monitoring Board (DSMB) recommended the continuation of the Phase 3 DRAGON trial without modifications, indicating confidence in the trial's design and preliminary results.
Business Wire8mon
Toshiba Starts Sample Shipments of Gate Driver IC for Three-Phase Brushless DC Motors in Diverse Automotive Applications - Business Wire
Minimizing functions allows utilization of one of the industry’s smallest[5] packages, the 6mm×6mm P-VQFN36-0606-0.50, and contributes to equipment miniaturization.
Yahoo Finance3y
Galectin Therapeutics Reports the Positive Outcome of the First Data and Safety Monitoring Board for NAVIGATE, its Seamless, Adaptive Phase 2b/3 Study of Belapectin in Patients ...
NORCROSS, Ga., April 14, 2022 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin-3, today reported the positive outcome of ...
Yahoo Finance1mon
BioXcel Therapeutics Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) to Continue SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of ...
The SERENITY At-Home Phase 3 trial is designed as a double-blind, placebo-controlled study to evaluate the safety of a 120 mcg dose of BXCL501 in 200 patients for acute treatment of agitation ...